Starbucks Corporation Message Board
-
All aboard.
-
-
-
Today's article by S A - by C.R. Jackson, titled as follows, DNDN: Is It Time To Give Up On Dendreon. Google it. It is a long article but definitely worth reading, if you are a TTNP investor. You might not like the article but they are facts and history worth reading about - especially now. Note FDA comparisons and outrage against FDA by almost everyone. Still holding TTNP. GLTA Longs!
-
GLTA Longs!
-
GLTA Longs!
-
Back up soon. GLTA Longs!
- Reply to
Any Thoughts To Jason's Reply Regarding Why He Predicts Dilution?
by gogolddndn •May 2, 2013 8:05 AMSorry, it cut off. Here's his complete response... By Jason... "Guys - you need to realize, yes Braeburn may bear the cost, should they choose to do so, for any required studies, but Titan, as a publicly traded company, has expenses outside of Probuphine.
The company is burning an estimated $750,000 per month Probuphine notwithstanding. Read their Form 10K. They clearly state they have enough cash to fund operations to June 2014 should Probuphine receive a CRL.
I'm expecting that the required clinical and preclinical work needed before they can re-file the NDA will take 24 months. Add another 6 months for review and you are probably 30 months away from any revised milestonepayment from Braeburn. Titan has enough cash for the next 12-14 months. They need to fund operations foranother 16-18 months beyond that. At $750,000 per month, they need to raise at least $12-15 million." -
for any required studies, but Titan, as a publicly traded company, has expenses outside of Probuphine.
The company is burning an estimated $750,000 per month Probuphine notwithstanding. Read their Form 10K. They clearly state they have enough cash to fund operations to June 2014 should Probuphine receive a CRL.
I'm expecting that the required clinical and preclinical work needed before they can re-file the NDA will take 24 months. Add another 6 months for review and you are probably 30 months away from any revised milestone payment from Braeburn. Titan has enough cash for the next 12-14 months. They need to fund operations foranother 16-18 months beyond that. At $750,000 per month, they need to raise at least $12-15 million." -
No different than the rest of the casino. Just went Long in AHs. GL
-
By Jason... "Guys - you need to realize, yes Braeburn may bear the cost, should they choose to do so, for any required studies, but Titan, as a publicly traded company, has expenses outside of Probuphine.
The company is burning an estimated $750,000 per month Probuphine notwithstanding. Read their Form 10K. They clearly state they have enough cash to fund operations to June 2014 should Probuphine receive a CRL.
I'm expecting that the required clinical and preclinical work needed before they can re-file the NDA will take 24 months. Add another 6 months for review and you are probably 30 months away from any revised milestone payment from Braeburn. Titan has enough cash for the next 12-14 months. They need to fund operations foranother 16-18 months beyond that. At $750,000 per month, they need to raise at least $12-15 million." -
Excellent. I agree. Also planning to buy more shares. Thank you and good luck.
-
-
Look up Jason's Article and read it. GL
-
"We have pushed back the launch of Probuphine from July 2013 to January 2016. We removed the $50 million milestone payment from Braeburn to Titan for approval. We have increased R&D expense in 2013, 2014, and 2015 to account for the added clinical work and the preparation in re-filing the Probuphine NDA in mid-2015. We have also added 40 million shares to our fully-diluted share count number given Titan's need for cash at some point during the second half of the year. Issuing 40 million shares at around $0.40 should raise enough money to fund operations to the new PDUFA in late 2015. We suspect that many of the existing warrants and stock options previously included in our model (with exercise prices over $2 per share) will now expire worthless. We have revised our fair-value calculation on Titan to $0.98 per share based on our revised DCF model."
. -
Guess we won't know for sure until Titan / Braeburn gets back with actual details. Anything is possible. GL
-
Google article just out by Jason Napodano - Seeking Alpha. Google it - won't let me post link here. GL
-
About what the FDA is asking, etc... FDA Rejection of Probuphine Hits Titan Hard